Synergistic Multimodal Cancer Therapy Using Glucose Oxidase@CuS Nanocomposites

ACS Appl Mater Interfaces. 2021 Sep 8;13(35):41464-41472. doi: 10.1021/acsami.1c12235. Epub 2021 Aug 27.

Abstract

Multimodal nanotherapeutic cancer treatments are widely studied but are often limited by their costly and complex syntheses that are not easily scaled up. Herein, a simple formulation of glucose-oxidase-coated CuS nanoparticles was demonstrated to be highly effective for melanoma treatment, acting through a synergistic combination of glucose starvation, photothermal therapy, and synergistic advanced chemodynamic therapy enabled by near-infrared irradiation coupled with Fenton-like reactions that were enhanced by endogenous chloride.

Keywords: Fenton reaction; cancer therapy; copper sulfide nanoparticles; glucose oxidase; starvation therapy.

MeSH terms

  • Animals
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / radiation effects
  • Antineoplastic Agents / therapeutic use*
  • Cell Line, Tumor
  • Combined Modality Therapy
  • Copper / chemistry
  • Copper / radiation effects
  • Copper / therapeutic use*
  • Drug Therapy
  • Enzymes, Immobilized / chemistry
  • Enzymes, Immobilized / therapeutic use
  • Glucose / chemistry
  • Glucose / metabolism
  • Glucose Oxidase / chemistry
  • Glucose Oxidase / therapeutic use*
  • Humans
  • Light
  • Male
  • Melanoma / drug therapy*
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Nanocomposites / chemistry
  • Nanocomposites / radiation effects
  • Nanocomposites / therapeutic use*
  • Photothermal Therapy

Substances

  • Antineoplastic Agents
  • Enzymes, Immobilized
  • Copper
  • Glucose Oxidase
  • Glucose
  • cupric sulfide